DNA sequencing for TP53 using precursor lesions from patients with pathogenic variants of BRCA1/2 was able to discover two types of p53 signatures, correlated with either a low or high risk of progression to STIC and ovarian cancer [13]. The gene discussed is TP53; the disease is ovarian cancer.